Exciting topline results from a #Phase2 trial in #Alz presented at #AAIC25 by #INmuneBio showing #solTNFinhibition by #XPro1595 in amyloid positive patients with 2+ biomarkers of inflammation in blood slowed cognitive decline in a 6 mo trial 🤓💪🏼💜🧠
2
0
0
0